Xeljanz is on a roll. The Pfizer immunology blockbuster scored a big new approval in psoriatic arthritis last year, and now it has won an FDA green light to treat ulcerative colitis. Plus, the approval includes the larger 10 mg dose, despite some internal agency questions about safety.
Reageer